Incyte
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
SIEGEL ERIC H. officer: EVP, General Counsel
 Common Stock 2,222 $104.86 $232,999
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Common Stock 3,936 $18.32 $72,108
Sale
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Common Stock 3,936 $18.32 $72,108
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Non-Qualified Stock Option (right to buy) 3,936 $18.32 $72,108
Option
WENQING YAO officer: EVP, Head of Discovery..
 Common Stock 5,000 $17.79 $88,950
Option
WENQING YAO officer: EVP, Head of Discovery..
 Non-Qualified Stock Option (right to buy) 5,000 $17.79 $88,950
Sale
WENQING YAO officer: EVP, Head of Discovery..
 Common Stock 786 $124.95 $98,211
Sale
SIEGEL ERIC H. officer: EVP, General Counsel
 Common Stock 2,222 $101.49 $225,511
Option
SIEGEL ERIC H. officer: EVP, General Counsel
 Common Stock 2,222 $18.32 $40,707
Option
SIEGEL ERIC H. officer: EVP, General Counsel
 Non-Qualified Stock Option (right to buy) 2,222 $18.32 $40,707
Sale
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Common Stock 3,937 $18.32 $72,126
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Common Stock 3,937 $18.32 $72,126
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Non-Qualified Stock Option (right to buy) 3,937 $18.32 $72,126
Option
HUBER REID M officer: EVP, Chief Scientific ..
 Common Stock 10,000 $18.32 $183,200
Option
HUBER REID M officer: EVP, Chief Scientific ..
 Non-Qualified Stock Option (right to buy) 10,000 $18.32 $183,200
Sale
HUBER REID M officer: EVP, Chief Scientific ..
 Common Stock 10,000 $18.32 $183,200
Option
BAKER JULIAN director, 10 percent owner
 Common Stock 4,623,926 N/A N/A
Sale
SIEGEL ERIC H. officer: EVP, General Counsel
 Common Stock 2,222 $130.69 $290,393
Option
SIEGEL ERIC H. officer: EVP, General Counsel
 Common Stock 2,222 $18.32 $40,707
Option
SIEGEL ERIC H. officer: EVP, General Counsel
 Non-Qualified Stock Option (right to buy) 2,222 $18.32 $40,707
Option
BAKER JULIAN director, 10 percent owner
 4.75% Convertible Senior Notes due 2015 64,000 $8.78 $561,600
Sale
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Common Stock 4,301 $130 $559,130
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Common Stock 3,937 $18.32 $72,126
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Non-Qualified Stock Option (right to buy) 3,937 $18.32 $72,126
Sale
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Common Stock 3,937 $18.32 $72,126
Sale
SIEGEL ERIC H. officer: EVP, General Counsel
 Common Stock 2,222 $107.69 $239,287
Option
SIEGEL ERIC H. officer: EVP, General Counsel
 Non-Qualified Stock Option (right to buy) 2,222 $18.32 $40,707
Option
SIEGEL ERIC H. officer: EVP, General Counsel
 Common Stock 2,222 $18.32 $40,707
Option
HUBER REID M officer: EVP, Chief Scientific ..
 Common Stock 8,397 $18.06 $151,608
Option
HUBER REID M officer: EVP, Chief Scientific ..
 Incentive Stock Option (right to buy) 8,397 $18.06 $151,608
Sale
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Common Stock 3,936 $18.32 $72,108
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Common Stock 3,936 $18.32 $72,108
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Non-Qualified Stock Option (right to buy) 3,936 $18.32 $72,108
Option
WENQING YAO officer: EVP, Head of Discovery..
 Non-Qualified Stock Option (right to buy) 5,000 $119.75 $598,750
Option
WENQING YAO officer: EVP, Head of Discovery..
 Common Stock 5,000 $119.75 $598,750
Sale
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Common Stock 70,217 $17.79 $1,249,160
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Common Stock 70,217 $17.79 $1,249,160
Sale
WENQING YAO officer: EVP, Head of Discovery..
 Common Stock 5,000 $119.75 $598,750
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Non-Qualified Stock Option (right to buy) 70,217 $17.79 $1,249,160
Option
WENQING YAO officer: EVP, Head of Discovery..
 Common Stock 7,850 $14.72 $115,552
Option
WENQING YAO officer: EVP, Head of Discovery..
 Non-Qualified Stock Option (right to buy) 7,850 $14.72 $115,552
Option
SIEGEL ERIC H. officer: EVP, General Counsel
 Non-Qualified Stock Option (right to buy) 2,222 $18.32 $40,707
Option
SIEGEL ERIC H. officer: EVP, General Counsel
 Common Stock 2,222 $18.32 $40,707
Sale
WENQING YAO officer: EVP, Head of Discovery..
 Common Stock 7,850 $14.72 $115,552
Sale
SIEGEL ERIC H. officer: EVP, General Counsel
 Common Stock 2,222 $113.61 $252,441
Sale
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Common Stock 3,937 $18.32 $72,126
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Non-Qualified Stock Option (right to buy) 3,937 $18.32 $72,126
Option
LEVY RICHARD S officer: EVP, Chief Drug Dev Of..
 Common Stock 3,937 $18.32 $72,126
Option
DALY JAMES M officer: EVP, Chief Commercial ..
 Non-Qualified Stock Option (right to buy) 11,691 $39.85 $465,886
Option
DALY JAMES M officer: EVP, Chief Commercial ..
 Common Stock 11,691 $39.85 $465,886

Showing 600 to 650 of 1431 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: